Expression and significance of EGFR, Her-2 and TOPO Ⅱ in esophageal canceration course

( views:84, downloads:0 )
YAO Su-xia(Department of Postgraduate, Shanxi Medical University, Taiyuan 030001, China)
LI Li()
YANG Xuan-qin()
SUN Rui-fang()
WANG Quan-hong()
WANG Xiao-ju()
Journal Title:
Volume 23, Issue 05, 2011
Key Word:
Esophageal neoplasms;Receptor, epidermal growth factor;Human epidermal growth factor receptor 2;Topoisomerase Ⅱ

Abstract: Objective To investigate the expression of EGFR, Her-2 and TOPO Ⅱ in esophageal canceration course, analyze the correlation between the expression and clinical pathological parameters and the correlation of the three genes. Methods EGFR, Her-2 and TOPO Ⅱ were detected by Tissue microarray technology and Envision immunohistochemistry method in 107 cases of esophageal carcinoma, including normal esophageal epithelium, esophageal intraepithelial neoplasia and esophageal squamous cell carcinoma. Results The positive expression rates of EGFR and TOPO Ⅱ display an improving trend from normal esophageal epithelium, intraepithelial neoplasia to carcinoma (P =0.031) in the above four groups. The positive expression rates of EGFR were 8.41 %, 7.94 %, 27.27 %, 50.47 %, and TOPO Ⅱ were 3.74 %, 4.76 %, 20.45 %, 43.93 %. Furthermore, the expression showed gradually incresing with histological grades advance (P =0.009). There was no correlation between EGFR or TOPO Ⅱ and gender, age, lymph node or distant metastasis (P >0.05). There was a positive correlation between EGFR and TOPO Ⅱ (r 1=0.410, P <0.05). There were no significance of Her-2 protein expression among the three groups(P >0.05), no correlation was obtained between Her-2 and gender, age, the depth of invasion or lymph node metastasis (P >0.05), no relationship between Her-2 and EGFR or TOPO Ⅱ either. Conclusion EGFR and TOPO Ⅱ are closely related to the occurrence and development of esophageal squamous cell carcinoma, their expressions all make a qualitative change in the esophageal high-grade intraepithelial neoplasia. The role of Her-2 in the development of esophageal squamous cell carcinoma is still not definite in Shanxi province.

  • [1]GaoY,Hu N,Han XY,etal.Family history of cancer and risk for esophageal and gastric cancer in Shanxi,China.BMC Cancer,2009,9:269.
  • [2]Sunpaweravong P,Sunpaweravong S,Puttawibul P,et al.Epidermal growth factor receptor and cyclin D1 are independently amplified and overexpressed in esophageal squamous cell carcinoma.J Cancer Res Clin Oncol,2005,131:111-119.
  • [3]唐郡,阎晓初,彭贵勇,等.食管鳞状细胞癌P-gP、GST2π、TopoⅡ的表达及临床意义.第三军医大学学报,2007,29:1692-1695.
  • [4]Molaei M,Pejhan S,Nayer BN,et al.Human epidermal growth factor receptor 2 family in colorectal adenocarcinoma:correlation with survival and clinicopathological findings.Eur J Gastroenterol Hepatol,2009,21:289-293.
  • [5]Fakih M,Vincent M.Adverse events associated with anti-EGFR therapies for the treatment of metastatic colorectal cancer.Current Oncol,2010,17:18-30.
  • [6]Cripps C,Winquist E,Devries MC,et al.Epidermal growth factor receptor targeted therapy in stages Ⅲ and Ⅳ head and neck cancer.Curr Oncol,2010,17:37-48.
  • [7]Gibault L,Metges JP,Conan-Charlet V,et al.Diffuse EGFR staining is associated with reduced overall survival in locally advanced oesophageal squamous cell cancer.Br J Cancer,2005,93:107-115.
  • [8]Reichelt U,Duesedau P,Tsourlakis MC,et al.Frequent homogeneous HER-2 amplification in primary and metastatic adenocarcinoma of the esophagus.Mod Pathol,2007,20:120-129.
  • [9]Akamatsu M,Matsumoto T,Yamasaki S,et al.c-erbB-2 oncoprotein expression related to chemoradioresistance in esophageal squamous cell carcinoma.Int J Radiat Oncol Biol Phys,2003,57:1323-1327.
  • [10]李洪胜,王远东,谭小军,等.EGFR及E-candherin表达与食管癌转移的关系.肿瘤研究与临床,2005,17:175-177.
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615